Intuitive Surgical (ISRG) July straddle 437 priced into quarter results

Go back to Intuitive Surgical (ISRG) July straddle 437 priced into quarter results

RBC Capital Reiterates Outperform Rating on Intuitive Surgical (ISRG)

July 19, 2024 6:31 AM EDT

RBC Capital analyst Shagun Singh reiterated an Outperform rating and $475.00 price target on Intuitive Surgical (NASDAQ: ISRG)

The analyst comments "ISRG reported Q2'24 results, delivering upside surprise of 2% on sales driven by better-than-expected procedure volume growth (+17% vs. +15.5%) and system placements (341 vs. 318);... More

Intuitive Surgical (ISRG) PT Lowered to $410 at Evercore ISI

July 19, 2024 5:07 AM EDT

Evercore ISI analyst Vijay Kumar lowered the price target on Intuitive Surgical (NASDAQ: ISRG) to $410.00 (from $425.00) while maintaining a In Line rating.

The analyst comments "Thesis Update: ISRG grew total rev by 14.5%, beating ST by ~190 bps this was driven by ~16% consumable rev growth, ~14% system and ~10% service rev growth. Consumable was driven by ~17% procedures growth (Beat ST by ~150 bps), and the CAGR vs 2019 being consistent QoQ. US procedures grew 14% despite bariatric declining -MSD (vs flat in 1Q24 & +10% in 4Q23), driven by strength in Ion (>80% growth) & general surgery. International came in better... More

Intuitive Surgical (ISRG) PT Raised to $469 at BTIG

July 19, 2024 4:58 AM EDT

BTIG analyst Ryan Zimmerman raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $469.00 (from $459.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy and raise our PT to $469 (from $459) following 2Q24 results. ISRG reported revenue of $2.009B (14.5% Y/Y) and adj. EPS of $1.78 vs. BTIG/Cons. estimates of $1.95B/$1.97B and adj. EPS of... More